1999
DOI: 10.1002/(sici)1096-9098(199908)71:4<250::aid-jso11>3.0.co;2-3
|View full text |Cite
|
Sign up to set email alerts
|

Special considerations in breast cancer risk and survival

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2000
2000
2015
2015

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 118 publications
0
3
0
Order By: Relevance
“…Reasons for differential breast cancer survival between white and black women have been studied extensively. Several studies documented treatment differences between black and white women,68–70 and others found treatment and survival differences between black and white patients diminished when controlling for socioeconomic factors, such as lack of insurance coverage 71, 72. Tumor and clinical characteristics such as estrogen receptor status, tumor size, tumor stage at diagnosis, and neutropenia also may influence the types and courses of treatment and survival,64, 73–76 although the differential availability of more biologically targeted treatment options also may contribute to variations in outcome.…”
Section: Discussionmentioning
confidence: 99%
“…Reasons for differential breast cancer survival between white and black women have been studied extensively. Several studies documented treatment differences between black and white women,68–70 and others found treatment and survival differences between black and white patients diminished when controlling for socioeconomic factors, such as lack of insurance coverage 71, 72. Tumor and clinical characteristics such as estrogen receptor status, tumor size, tumor stage at diagnosis, and neutropenia also may influence the types and courses of treatment and survival,64, 73–76 although the differential availability of more biologically targeted treatment options also may contribute to variations in outcome.…”
Section: Discussionmentioning
confidence: 99%
“…Of these, 33 papers were initially excluded as they did not examine dietary fat and breast cancer mortality. Of the 49 articles which remained, the following papers were excluded: 5 randomised controlled trials (Chlebowski et al, 2006;Pierce et al, 2007;Winters et al, 2004;Stolley et al, 2009;Hoy et al, 2009), 1 ecological study (Kesteloot et al, 1994), 18 reviews (Wynder et al, 1986;Chlebowski et al, 1992;Wynder et al, 1992;Colditz, 1993;Cohen et al, 1993;Ganz & Schag, 1993;Nixon, 1996;Stoll, 1996;Wynder et al, 1997;Jatoi & Loprinzi, 1999;Newman et al, 1999;Rock & Demark-Wahnefried, 2001;Blackburn et al, 2003;Holmes & Kroenke, 2004;Blackburn & Wang, 2007;Kellen et al, 2009), 7 editorials/letters/supplements/communications (Hebert & Wynder, 1987;Lipmann, 1987;Thiébaut et al, 2006;Kurt & Altundag, 2007;Pierce 8 et al, 2007;Gapstur & Khan, 2007;Nelson, 2008) one study which examined marine fatty acid intake (Patterson et al, 2011), one study which presented results as foods and not nutrients (Hebert et al, 1998) and one study which did not provide usable estimates for dietary fat and breast cancer survival (Holm et al, 1993).…”
Section: Inclusionmentioning
confidence: 99%
“…710 Socioeconomic factors have also been shown to play a role in creating this disparity, e.g., lack of insurance coverage, 11, 12 reduced access to screening 13 and treatment, 1416 and treatment differences. 15, 17, 18 …”
Section: Introductionmentioning
confidence: 99%